---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-329622"
form_type: "8-K"
ticker: "LNTH"
cik: "0001521036"
company_name: "Lantheus Holdings, Inc."
filed_at: "2026-08-03T12:37:46+00:00"
generated_at: "2026-08-03T12:40:06.738509+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Curium to acquire Lantheus for up to $114.50/share ($8.0B); 38% premium to 60-day VWAP

## Summary
- Total consideration up to $114.50/share: $102.50 cash at closing plus up to $12.00 in CVRs tied to commercial milestones through 2030.
- Aggregate transaction value up to $8.0B; premiums of 38% (60-day VWAP), 29% (30-day VWAP), and 21% (unaffected close).
- Lantheus Board unanimously approved; transaction expected to close in first half of 2027, subject to shareholder and regulatory approvals.
- Lantheus pauses CEO search, suspends FY2026 guidance, and will not host Q2 2026 earnings call due to pending merger.
- Combined company will serve oncology, neurology, and cardiology patients across more than 70 countries.

## SEC filing metadata
- accession: 0001193125-26-329622
- form_type: 8-K
- ticker: LNTH
- cik: 0001521036
- company_name: Lantheus Holdings, Inc.
- filed_at: 2026-08-03T12:37:46+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1521036/000119312526329622/0001193125-26-329622-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1521036/000119312526329622/d148563d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-329622
- JSON: https://secwatch.observer/filing/0001193125-26-329622.json
- Plain text: https://secwatch.observer/filing/0001193125-26-329622.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.